Conexeu Sciences Inc. (CNXU) vs Fortress Biotech, Inc. (FBIO)

Conexeu Sciences Inc. and Fortress Biotech, Inc. are both Biotechnology companies. Conexeu Sciences Inc. and Fortress Biotech, Inc. are of similar size ($65.4M and $61.4M). Conexeu Sciences Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the higher return on invested capital (−41.3% vs −234.6%). Across the 13 metrics below, Fortress Biotech, Inc. leads on 10 and Conexeu Sciences Inc. on 3.

Valuation

Metric CNXU FBIO Biotechnology median
P/E n/m 0.56 10.26
P/S n/m 0.85 9.18
P/B 9.64 0.28 2.05
Price to free cash flow n/m 0.68 24.81
EV/EBITDA n/m 4.91 0.65
EV/Sales n/m (1.46) 8.98
Earnings yield (29.81%) 177.17% (34.89%)
Free cash flow yield (18.82%) 146.75% (24.52%)

Profitability

Metric CNXU FBIO Biotechnology median
Gross margin — 65.59% 65.16%
Operating margin 0.00% (42.61%) 0.00%
Net margin 0.00% 150.98% 0.00%
Free cash flow margin 0.00% 183.80% 0.00%
Return on equity (458.40%) 84.91% (50.12%)
Return on assets (354.37%) 43.38% (45.60%)
Return on invested capital (234.60%) (41.34%) 0.00%

Growth

Metric CNXU FBIO Biotechnology median
Revenue growth (TTM) — 15.46% 6.26%
EPS growth (last fiscal year) (342.80%) 97.40% 29.88%
Revenue growth, 5-year CAGR — 6.77% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CNXU FBIO Biotechnology median
Debt to equity 0.00 0.17 0.00
Current ratio 5.31 3.96 4.89
Net debt to EBITDA 1.23 0.43 1.01

Dividend

Metric CNXU FBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNXU FBIO Biotechnology median
Market cap 65.36m 61.36m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack